Hiroko Kitahara

481 total citations
17 papers, 406 citations indexed

About

Hiroko Kitahara is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hiroko Kitahara has authored 17 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Hiroko Kitahara's work include Peptidase Inhibition and Analysis (3 papers), Head and Neck Cancer Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Hiroko Kitahara is often cited by papers focused on Peptidase Inhibition and Analysis (3 papers), Head and Neck Cancer Studies (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Hiroko Kitahara collaborates with scholars based in Japan and United Kingdom. Hiroko Kitahara's co-authors include Koroku Kato, Shuichi Kawashiri, Kunio Yoshizawa, Hiroyuki Nakamura, Etsuhide Yamamoto, George Bou–Gharios, Yutaka Kobayashi, Shinichi Nozaki, Natsuyo Noguchi and Kazuhiro Ooi and has published in prestigious journals such as International Journal of Oncology, Journal of Oral Pathology and Medicine and Oncology Reports.

In The Last Decade

Hiroko Kitahara

16 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Kitahara Japan 11 234 186 102 62 58 17 406
Giórgia Gobbi da Silveira Brazil 9 161 0.7× 182 1.0× 84 0.8× 39 0.6× 33 0.6× 12 334
Sonja E. Volker United States 4 101 0.4× 308 1.7× 107 1.0× 30 0.5× 43 0.7× 5 408
Xinping Yang United States 11 142 0.6× 263 1.4× 125 1.2× 37 0.6× 65 1.1× 15 425
Hsuan-Yu Peng Taiwan 9 72 0.3× 285 1.5× 219 2.1× 29 0.5× 29 0.5× 10 368
Kyle M. LaPak United States 6 113 0.5× 187 1.0× 55 0.5× 63 1.0× 55 0.9× 11 353
М. Р. Патышева Russia 9 189 0.8× 231 1.2× 106 1.0× 61 1.0× 299 5.2× 31 525
Nilesh Gardi India 12 96 0.4× 204 1.1× 103 1.0× 32 0.5× 32 0.6× 28 329
H Takeyama Japan 5 233 1.0× 183 1.0× 111 1.1× 29 0.5× 92 1.6× 13 410
Е. В. Кайгородова Russia 11 189 0.8× 122 0.7× 87 0.9× 45 0.7× 46 0.8× 41 333
Yanling Fan China 9 130 0.6× 249 1.3× 101 1.0× 61 1.0× 50 0.9× 11 384

Countries citing papers authored by Hiroko Kitahara

Since Specialization
Citations

This map shows the geographic impact of Hiroko Kitahara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Kitahara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Kitahara more than expected).

Fields of papers citing papers by Hiroko Kitahara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Kitahara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Kitahara. The network helps show where Hiroko Kitahara may publish in the future.

Co-authorship network of co-authors of Hiroko Kitahara

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Kitahara. A scholar is included among the top collaborators of Hiroko Kitahara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Kitahara. Hiroko Kitahara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kobayashi, Yutaka, Hiroko Kitahara, Akira Tanaka, et al.. (2019). Selectively high efficacy of eribulin against high‑grade invasive recurrent and/or metastatic squamous cell carcinoma of the head and neck. Oncology Letters. 17(6). 5064–5072. 1 indexed citations
2.
Kato, Koroku, Yutaka Kobayashi, Hiroko Kitahara, et al.. (2018). Clinicopathological Significance of the ET Axis in Human Oral Squamous Cell Carcinoma. Pathology & Oncology Research. 25(3). 1083–1089. 2 indexed citations
3.
4.
Kitahara, Hiroko, et al.. (2016). Eribulin sensitizes oral squamous cell carcinoma cells to cetuximab via induction of mesenchymal-to-epithelial transition. Oncology Reports. 36(6). 3139–3144. 22 indexed citations
5.
Kitahara, Hiroko, Yutaka Kobayashi, Koroku Kato, et al.. (2016). Regulation of PD-L1 expression in a high-grade invasive human oral squamous cell carcinoma microenvironment. International Journal of Oncology. 50(1). 41–48. 67 indexed citations
6.
Kitahara, Hiroko, Kazuhiro Ooi, Koroku Kato, et al.. (2015). Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition. Oncology Letters. 11(1). 201–207. 41 indexed citations
7.
Kato, Koroku, et al.. (2014). Prognostic value of vascular endothelial growth factors A and C in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 43(7). 514–520. 30 indexed citations
8.
Yoshizawa, Kunio, Shinichi Nozaki, Aki Kato, et al.. (2012). Loss of claudin-7 is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Oncology Reports. 29(2). 445–450. 21 indexed citations
9.
Kato, Koroku, Shuichi Kawashiri, Kunio Yoshizawa, et al.. (2011). Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis. Journal of Oral Pathology and Medicine. 40(9). 693–698. 38 indexed citations
10.
Nozaki, Shinichi, et al.. (2011). Primary extracranial meningioma of the maxillary sinus presenting as buccal swelling. Asian Journal of Oral and Maxillofacial Surgery. 23(3). 134–137. 3 indexed citations
11.
Yamamoto, Etsuhide, Shuichi Kawashiri, Koroku Kato, et al.. (2009). Biological characteristics of the most invasive squamous cell carcinoma (Grade 4D) of the oral cavity. Journal of Japanese Society of Oral Oncology. 21(3). 131–169. 1 indexed citations
12.
Yamamoto, Etsuhide, Shuichi Kawashiri, Koroku Kato, et al.. (2009). . Journal of Japanese Society of Oral Oncology. 21(3). 131–169. 2 indexed citations
13.
Yoshizawa, Kunio, Shinichi Nozaki, Hiroko Kitahara, et al.. (2009). Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 38(6). 535–539. 31 indexed citations
14.
Kawashiri, Shuichi, Akira Tanaka, Natsuyo Noguchi, et al.. (2009). Integrin Expression Levels Correlate with Invasion, Metastasis and Prognosis of Oral Squamous Cell Carcinoma. Pathology & Oncology Research. 15(3). 429–436. 18 indexed citations
15.
Kato, Koroku, Shuichi Kawashiri, Kunio Yoshizawa, Hiroko Kitahara, & Etsuhide Yamamoto. (2008). Apoptosis‐associated markers and clinical outcome in human oral squamous cell carcinomas. Journal of Oral Pathology and Medicine. 37(6). 364–371. 29 indexed citations
16.
Noguchi, Natsuyo, Shuichi Kawashiri, Akira Tanaka, et al.. (2007). Experimental study of the effects of fibroblast growth inhibitor on invasion and metastasis of oral squamous cell carcinoma. Japanese Journal of Oral & Maxillofacial Surgery. 53(10). 580–587. 1 indexed citations
17.
Yoshizawa, Kunio, et al.. (2007). Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines. Oncology Reports. 18(4). 987–91. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giórgia Gobbi da Silveira Breakdown of academic impact, for papers by Sonja E. Volker Breakdown of academic impact, for papers by Xinping Yang Breakdown of academic impact, for papers by Hsuan-Yu Peng Breakdown of academic impact, for papers by Kyle M. LaPak Breakdown of academic impact, for papers by М. Р. Патышева Breakdown of academic impact, for papers by Nilesh Gardi Breakdown of academic impact, for papers by H Takeyama Breakdown of academic impact, for papers by Е. В. Кайгородова Breakdown of academic impact, for papers by Yanling Fan
Rankless by CCL
2026